Global Ribonucleic Acid (RNA) Sequencing Market Growth Accelerates: Strategic Forecast Predicts $8.34 Billion by 2029

Use code ONLINE20 to get 20% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.

What Will the Ribonucleic Acid (RNA) Sequencing Industry Market Size Be by 2025?
The market for ribonucleic acid (RNA) sequencing has experienced substantial expansion recently, projected to increase from its 2024 valuation of $3.25 billion to $3.96 billion by 2025, reflecting a compound annual growth rate (CAGR) of 21.8%. This upward trajectory during the historical period stems from several key factors, including an escalation in drug development efforts, the rising incidence of genetic conditions and specific target ailments, augmented deployment of compact, portable devices, greater adoption of biomarker analysis, escalating requirements for tailored medical treatments, and a growing patient pool suffering from cancer.

What's the Long-Term Growth Forecast for the Ribonucleic Acid (RNA) Sequencing Market Size Through 2029?
Projections indicate that the market centered around ribonucleic acid (RNA) sequencing is poised for considerable expansion in the near term, aiming to reach a substantial $8.34 billion by the year 2029, reflecting a robust compound annual growth rate (CAGR) of 20.5% throughout that projection timeframe; this upward trajectory is primarily fueled by an increasing need for swift and precise disease identification methods, the broader implementation of real-time polymerase chain reaction techniques, surging requirements for immediate, point-of-care diagnostic assessments, the escalation of infectious disease occurrences globally, and a growing reliance on companion diagnostics, while key developments anticipated to shape this market during the forecast include advancements in monitoring and detecting illnesses, crucial activities in drug discovery, the processes of target validation, pinpointing useful biomarkers, evolution in DNA sequencing technologies, progress within diagnostic testing methodologies, the implementation of next-generation sequencing (NGS), the use of microfluidics, the development of lab-on-a-chip systems, and innovation in sophisticated molecular diagnostic offerings.

View the full report here:
https://www.thebusinessresearchcompany.com/report/ribonucleic-acid-rna-sequencing-global-market-report

What Are the Key Growth Drivers Fueling the Ribonucleic Acid (RNA) Sequencing Market Expansion?
The future expansion of the ribonucleic acid (RNA) sequencing market is anticipated to be fueled by a growing dedication to individualized healthcare strategies, often termed precision medicine. This innovative medical methodology, which tailors treatment and preventative care based on an individual's unique genetic makeup, environmental factors, and daily habits, holds significant promise due to advancements in genomic understanding, the rising intricacy of various ailments, regulatory backing, and the prospect of delivering more efficacious interventions. RNA sequencing methodologies are employed to ascertain the exact order and measure the abundance of RNA molecules present in a specimen, thereby facilitating deep dives into transcriptome profiles, gene expression characteristics, variations in RNA splicing, and modifications to RNA structures. As an illustration, data from the Personalized Medicine Coalition, a non-profit entity based in the United States, revealed that the FDA authorized sixteen new personalized treatments for individuals suffering from uncommon conditions throughout 2023, a notable increase from the six approvals granted in 2022. Consequently, the heightened emphasis placed on precision medicine acts as a key catalyst for the growth observed within the ribonucleic acid (RNA) sequencing sector.

Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=15665&type=smp

What Are the Key Trends Driving Ribonucleic Acid (RNA) Sequencing Market Growth?
Key industry players within the ribonucleic acid (RNA) sequencing sector are channeling their efforts into RNA next-generation sequencing assays, aiming to enhance patient outcomes via insights derived from data and the advancement of personalized medicine. The RNA next-generation sequencing assay functions as an exhaustive exome sequencing system, integrating cutting-edge genomic sequencing methodologies to scrutinize an individual's comprehensive exome profile. To illustrate this, in June of 2023, Tempus, an American firm specializing in precision medicine technology, launched Tempus xR, its novel standalone RNA next-generation sequencing assay. This sophisticated assay, specifically engineered for solid tumor applications, furnishes an in-depth assessment of the complete transcriptome, pinpointing clinically relevant fusions across more than one hundred selected genes, alongside identifying aberrant splicing patterns for both MET Exon 14 and EGFRvIII, thereby serving clinicians particularly interested in RNA fusions or splicing variations, as well as various providers, research entities, and biopharmaceutical organizations requiring intricate RNA sequencing data from their current biospecimens.

How Is the Ribonucleic Acid (RNA) Sequencing Market Segmented?
The ribonucleic acid (rna) sequencingmarket covered in this report is segmented -

1) By Product Type: Instruments; Reagents And Kits; Software
2) By Technology: Single Molecule Based Sequencing; Sequence By Synthesis Technology; Nanopore Sequencing Technology; Ion Torrent Semiconductor Sequencing
3) By Applications: Diagnostics; Drug Discovery; Translational Medicine; Other Applications
4) By End User: Research And Academia; Hospitals And Clinics; Pharmaceutical And Biotechnology Companies; Other End Users

Subsegments:
1) By Instruments: Next-Generation Sequencers; Microarray Instruments; Single-Cell Rna Sequencing Instruments
2) By Reagents And Kits: Rna Extraction Kits; Rna Sequencing Kits; Library Preparation Kits
3) By Software: Data Analysis Software; Data Management Software; Bioinformatics Software

Tailor your insights and customize the full report here:
https://www.thebusinessresearchcompany.com/customise?id=15665&type=smp

Which Companies Are Leading the Charge in Ribonucleic Acid (RNA) Sequencing Market Innovation?
Major companies operating in the ribonucleic acid (RNA) sequencing market are F. Hoffmann-La Roche Ltd., Thermo Fisher Scientific Inc., Danaher Corporation, Merck KGaA, Becton, dic*kinson and Company, GE HealthCare Technologies Inc., Eurofins Scientific SE, Agilent Technologies Inc., Illumina Inc., PerkinElmer Inc., bioMérieux SA, Beckman Coulter Inc., Sysmex Corporation, Bio-Rad Laboratories Inc., QIAGEN N.V., Tecan Genomics Inc., Natera Inc., Myriad Genetics Inc., BGI Genomics Co Ltd., Takara Bio Inc., Cepheid, NeoGenomics Laboratories Inc., Abcam Limited, Oxford Nanopore Technologies plc, Pacific Biosciences of California Inc., Macrogen Inc., Standard BioTools Inc., Ambry Genetics Corporation, Biocartis SA, CD Genomics

Which Regions Are Leading the Global Ribonucleic Acid (RNA) Sequencing Market in Revenue?
North America was the largest region in the ribonucleic acid (RNA) sequencing market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the ribonucleic acid (RNA) sequencing market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Purchase the full report today:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=15665

This Report Supports:
1.Business Leaders & Investors - To identify growth opportunities, assess risks, and guide strategic decisions.
2.Manufacturers & Suppliers - To understand market trends, customer demand, and competitive positioning.
3.Policy Makers & Regulators - To track industry developments and align regulatory frameworks.
4.Consultants & Analysts - To support market entry, expansion strategies, and client advisory work.

Reach out to us:
The Business Research Company: https://www.thebusinessresearchcompany.com/,
Americas +1 310-496-7795,
Europe +44 7882 955267,
Asia & Others +44 7882 955267 & +91 8897263534,
Email us at info@tbrc.info.

Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Learn More About The Business Research Company
With over 17500+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead.Our flagship product, the Global Market Model (GMM), is a premier market intelligence platform delivering comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.